Transparency Notification from Ion Beam Applications SA
Ion Beam Applications SA, known for its leading role in proton therapy for cancer treatment, has recently issued a notification detailing a significant shareholding change. This notification adheres to legal requirements regarding the disclosure of major holdings, vital for maintaining transparency in corporate governance.
Understanding the Notification
This transparency notification follows a previous notice received by the company concerning the acquisition of securities that caused a breach of the 2% ownership threshold. Specifically, on May 30, the company crossed this threshold, necessitating the current disclosure.
Key Information Included in the Notification
The notification outlines the reason for the announcement as an acquisition or disposal of voting securities. It identifies the company as being subjected to the notification requirement, indicating that this change is precipitated by parent company activity.
Details of the Shareholding Changes
Among the significant entities involved, Ion Beam Applications SA indicated that it holds 380,002 voting rights, equating to approximately 2.54% of the total voting rights. IBA Investments SRL also plays a critical role in this shift with its shareholding specifics. Collectively, these changes reflect a notable shift in the voting landscape of the company.
About Ion Beam Applications SA
Ion Beam Applications SA stands at the forefront of proton therapy technology, playing a crucial role in oncology through its advanced treatment solutions. The company supplies a wide range of equipment and services, and employs around 2,100 professionals globally. IBA's dedication to excellence and its status as a certified B Corporation highlight its commitment to social and environmental stewardship.
Financial Overview
The notification further discloses that the total number of voting rights now stands at 1,123,698, constituting 2.80% of the overall voting rights after the latest transaction. This development signifies a substantial financial realignment within the company.
Contact Information for Further Inquiries
For any inquiries regarding this notification, interested parties are encouraged to reach out to Elena De Landy, who serves as the paralegal overseeing Corporate Affairs and Insurance. Contact can be made via email, ensuring that communications remain smooth and responsive.
Frequently Asked Questions
What triggered the transparency notification from IBA?
The notification was triggered after the company crossed a 2% shareholding threshold following the acquisition of voting securities.
What is the total number of voting rights after the acquisition?
Post-acquisition, the total number of voting rights is 1,123,698, representing 2.80% of total voting rights.
Who issued the transparency notification?
The notification was issued by Ion Beam Applications SA to comply with regulatory requirements concerning major shareholding disclosures.
What contributions does Ion Beam Applications SA provide?
IBA specializes in proton therapy, industrial sterilization, and other critical healthcare services, making invaluable contributions to cancer treatment.
How many employees does IBA have worldwide?
IBA employs approximately 2,100 people across the globe, reflecting its extensive operational capacity and influence in the market.
